GSD NovaGen SARS-CoV-2 Ag rapid test completes the diagnostic panel of the Gold Standard Diagnostics Group for SARS-CoV-2 diagnostics: ELISA, RT-PCR, and RNA extraction kits. This lateral-flow test meets the WHO performance criteria (sensitivity higher than 80%; specificity higher than 97%) for use in the global fight against COVID-19.
- Current mutant strains can be detected (UK, South Africa, Brazil)
- Easy specimen collection: nasal and nasopharyngeal swabs
- Fast results in 15 minutes
- Intuitive visual interpretation
- High sensitivity and specificity
- Easy to perform: no special equipment needed
It is intended for the qualitative detection of SARS-CoV-2 Nucleocapsid (N) Protein antigens present in respiratory samples.
Certifications: CE-IVD marked.